Rotariu P, Yohannes P, Alexianu M, Rosner D, Lee B R, Lucan M, Smith A D
Department of Urology, Albert Einstein College of Medicine, Long Island Jewish Medical Center Campus, New Hyde Park, New York, USA.
J Endourol. 2001 Dec;15(10):979-83. doi: 10.1089/089277901317203047.
Extrinsic ureteral obstruction caused by various malignancies often necessitates urinary diversion. The use of single ureteral stents as a form of urinary diversion results in a high failure rate, while the use of two ipsilateral stents has shown promising results. We report our experience using the latter technique.
Between 1996 and 2001, four male and three female patients with a mean age of 65 years (range 37-95 years) who had extrinsic compression of the ureters underwent single stent management to relieve obstruction. Ureteral obstruction was secondary to prostate cancer (N = 3), cervical cancer (2), non-Hodgkin's lymphoma (1), and transitional-cell cancer of the bladder and ureter (1). After failure of such management, two 7F stents or a combination of 8F/6F double-J ureteral stents were placed. The stents were changed every 4 to 6 months. Follow-up included serial renal ultrasound scans and serum creatinine measurements.
Ureteral stricture length ranged from 2 to 4 cm. Insertion of two double-J ureteral stents in a single ureter was successful in all cases. During the mean follow-up of 16 months (range 1-38 months), the ureteral stents were tolerated by all patients, without significant discomfort. Marked improvement of hydronephrosis and alleviation of flank pain was noted in all patients. Three patients have died at 1 to 3 months. Renal function improved, with a mean decline in the serum creatinine concentration from 3.2 mg/dL to 1.48 mg/dL in the five patients tested.
Simultaneous placement of two double-J ureteral stents for the management of ureteral obstruction secondary to a malignancy is a safe and effective technique.
各种恶性肿瘤导致的输尿管外梗阻常需进行尿流改道。使用单根输尿管支架作为尿流改道的一种方式失败率较高,而使用两根同侧支架已显示出有前景的结果。我们报告使用后一种技术的经验。
1996年至2001年间,7例患者(4例男性,3例女性),平均年龄65岁(范围37 - 95岁),因输尿管受到外源性压迫接受单根支架置入以缓解梗阻。输尿管梗阻继发于前列腺癌(3例)、宫颈癌(2例)、非霍奇金淋巴瘤(1例)以及膀胱和输尿管移行细胞癌(1例)。在这种治疗失败后,置入两根7F支架或8F/6F双J型输尿管支架组合。支架每4至6个月更换一次。随访包括系列肾脏超声扫描和血清肌酐测量。
输尿管狭窄长度为2至4厘米。在所有病例中,在单根输尿管内成功置入两根双J型输尿管支架。在平均16个月(范围1 - 38个月)的随访期间,所有患者均耐受输尿管支架,无明显不适。所有患者均出现肾积水明显改善和胁腹痛减轻。3例患者在1至3个月时死亡。5例接受检测的患者肾功能改善,血清肌酐浓度平均从3.2毫克/分升降至1.48毫克/分升。
同时置入两根双J型输尿管支架治疗继发于恶性肿瘤的输尿管梗阻是一种安全有效的技术。